{
    "title": "Idorsia considers cash-raising options after 2019 loss",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7973299/Idorsia-considers-cash-raising-options-2019-loss.html",
    "date": "2020-02-06",
    "keywords": [
        "idorsia",
        "drug",
        "biotech",
        "cash",
        "muller",
        "john",
        "miller",
        "pipeline",
        "company",
        "year",
        "daridorexant",
        "start",
        "johnson",
        "clozel",
        "coronavirus",
        "recruitment",
        "paul",
        "arnold",
        "spinoff",
        "mix",
        "capital",
        "increase",
        "development",
        "finance",
        "chief",
        "andre",
        "market",
        "liquidity",
        "credit",
        "reserve",
        "pioneer",
        "jeanpaul",
        "companys",
        "founder",
        "pile",
        "point",
        "licensing",
        "treatment",
        "clazosentan",
        "equity",
        "route",
        "combination",
        "trading",
        "value",
        "business",
        "actelion",
        "approval",
        "prospect",
        "dora",
        "launch",
        "close",
        "crisis",
        "china",
        "pair",
        "hypertension",
        "medicine",
        "aprocitentan",
        "cenerimod",
        "halt",
        "everything",
        "reporting",
        "kim",
        "coghill",
        "david",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}